共 50 条
- [21] Management of Diabetic Retinopathy in the Anti-Vascular Endothelial Growth Factor Era RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (03): : 461 - 463
- [25] RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (09): : 1793 - 1803
- [26] REPORT OF SAFETY OF THE USE OF A SHORT 32G NEEDLE FOR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR RETINOPATHY OF PREMATURITY RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (06): : 1251 - 1255
- [27] Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity FRONTIERS IN PEDIATRICS, 2022, 10
- [28] Efficacy of four anti-vascular endothelial growth factor agents and laser treatment for retinopathy of prematurity: A network meta-analysis BIOMOLECULES AND BIOMEDICINE, 2024, 24 (04): : 676 - 687
- [29] FLUORESCEIN ANGIOGRAPHY EVALUATION OF CHILDREN PREVIOUSLY TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY FOR RETINOPATHY OF PREMATURITY RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (05): : 901 - 908
- [30] Anti-vascular endothelial growth factor for proliferative diabetic retinopathy COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):